Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Cost effectiveness of surveillance for GI cancers

    Access Status
    Fulltext not available
    Authors
    Omidvari, A.
    Meester, R.
    Lansdorp_Vogelaar, Iris
    Date
    2016
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Omidvari, A. and Meester, R. and Lansdorp_Vogelaar, I. 2016. Cost effectiveness of surveillance for GI cancers. Best Practice and Research: Clinical Gastroenterology. 30 (6): pp. 879-891.
    Source Title
    Best Practice and Research: Clinical Gastroenterology
    DOI
    10.1016/j.bpg.2016.09.001
    ISSN
    1521-6918
    URI
    http://hdl.handle.net/20.500.11937/49932
    Collection
    • Curtin Research Publications
    Abstract

    Gastrointestinal (GI) diseases are among the leading causes of death in the world. To reduce the burden of GI diseases, surveillance is recommended for some diseases, including for patients with inflammatory bowel diseases, Barrett's oesophagus, precancerous gastric lesions, colorectal adenoma, and pancreatic neoplasms. This review aims to provide an overview of the evidence on cost-effectiveness of surveillance of individuals with GI conditions predisposing them to cancer, specifically focussing on the aforementioned conditions. We searched the literature and reviewed 21 studies. Despite heterogeneity of studies in terms of settings, study populations, surveillance strategies and outcomes, most reviewed studies suggested at least some surveillance of patients with these GI conditions to be cost-effective. For some high-risk conditions frequent surveillance with 3-month intervals was warranted, while for other conditions, surveillance may only be cost-effective every 10 years. Further studies based on more robust effectiveness evidence are needed to inform and optimise surveillance programmes for GI cancers.

    Related items

    Showing items related by title, author, creator and subject.

    • Use of the Global Alliance for Musculoskeletal Health survey module for estimating the population prevalence of musculoskeletal pain: Findings from the Solomon Islands
      Hoy, D.; Raikoti, T.; Smith, E.; Tuzakana, A.; Gill, T.; Matikarai, K.; Tako, J.; Jorari, A.; Blyth, F.; Pitaboe, A.; Buchbinder, R.; Kalauma, I.; Brooks, P.; Lepers, C.; Woolf, A.; Briggs, Andrew; March, L. (2018)
      Background: Musculoskeletal (MSK) conditions are common and the biggest global cause of physical disability. The objective of the current study was to estimate the population prevalence of MSK-related pain using a ...
    • Developing spatio-temporal prediction models for arbovirus activity in nothern Australia based on remotely sensed bioclimatic variables
      Klingseisen, Bernhard; Corner, Robert; Stevenson, Mark (2011)
      Vector-borne diseases pose an ongoing threat to public and animal health in the north ofAustralia. A number of surveillance programs are in place to determine the extent of virus activityand control the risk, but these ...
    • Effectiveness of general practice nurse interventions in cardiac risk factor reduction amongst adults
      Halcomb, E.; Moujalli, S.; Griffiths, R.; Davidson, Patricia (2007)
      Background: Cardiovascular disease is the leading cause of death for adults in Australia. In recent years there has been a shift in health service delivery from institutional to community-based care for chronic conditions, ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.